neuroendocrine tumors

Showing 1 - 25 of 236

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

Recruiting
  • VHL Pancreatic Neuroendocrine Tumors
  • +2 more
  • 68-Gallium DOTATATE
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2022

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • (no location specified)
Aug 23, 2022

Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +6 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Aug 19, 2022

Subjects Previously Enrolled on NCI Surgery Branch Studies

Enrolling by invitation
  • Melanoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 18, 2022

    Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in

    Not yet recruiting
    • Stage I Testicular Seminoma
    • +13 more
    • Oncological Follow-up
    • Amiens, France
    • +2 more
    Aug 12, 2022

    Neuroendocrine Tumors Trial in Worldwide (Data collection)

    Active, not recruiting
    • Neuroendocrine Tumors
    • Data collection
    • Melbourne, Australia
    • +6 more
    Aug 11, 2022

    Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)

    Recruiting
    • Prostate Cancer Metastatic
    • Neuroendocrine Tumors
    • Atlanta, Georgia
    • +1 more
    Aug 4, 2022

    Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)

    Recruiting
    • Neuroendocrine Tumors
    • Gallium-68 NODAGA-JR11
    • Beijing, Beijing, China
    • +1 more
    Jul 27, 2022

    Neuroendocrine Tumors Trial in New York (177Lu-DOTA-EB-TATE, Amino Acid Solution)

    Recruiting
    • Neuroendocrine Tumors
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 22, 2022

    Neuroendocrine Tumors Trial in China (Lutetium[177Lu] Oxodotreotide Injection, Octreotide LAR)

    Not yet recruiting
    • Neuroendocrine Tumors
    • Lutetium[177Lu] Oxodotreotide Injection
    • Octreotide LAR
    • Beijing, Beijing, China
    • +20 more
    Jul 25, 2022

    Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

    Terminated
    • Neoplasms
    • +27 more
    • Culver City, California
    • +28 more
    Jul 25, 2022

    Neuroendocrine Tumors Trial in Seoul (Lanreotide autogel)

    Recruiting
    • Neuroendocrine Tumors
    • Lanreotide autogel
    • Seoul, Korea, Republic of
      Changhoon Yoo
    Jul 18, 2022

    Neuroendocrine Tumors Trial in Sherbrooke (68Ga-DOTA-TATE)

    Recruiting
    • Neuroendocrine Tumors
    • 68Ga-DOTA-TATE
    • Sherbrooke, Quebec, Canada
      CHUS
    Jul 18, 2022

    Neuroendocrine Tumors - Patient Reported Outcomes

    Enrolling by invitation
    • Neuroendocrine Tumors
    • +3 more
      • Gainesville, Florida
      • +13 more
      Jul 7, 2022

      Gastro-enteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Iowa City (Lutathera, Azedra)

      Not yet recruiting
      • Gastro-enteropancreatic Neuroendocrine Tumor
      • Neuroendocrine Tumors
      • Iowa City, Iowa
        Holden Comprehensive Cancer Center
      Jul 7, 2022

      Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

      Terminated
      • Neuroendocrine Tumors
      • +2 more
      • Denver, Colorado
      • +2 more
      Jul 5, 2022

      Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

      Recruiting
      • Neuroendocrine Tumors
      • Carcinoma, Neuroendocrine
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jul 6, 2022

        Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma Trial in France (Blood sampling to build population

        Not yet recruiting
        • Digestive Cancer
        • +4 more
        • Blood sampling to build population pharmacokinetics model
        • Auxerre, France
        • +23 more
        Jul 1, 2022

        Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)

        Recruiting
        • Neuroendocrine Tumors
        • Neuroendocrine Carcinoma
        • Göttingen, Lower Saxony, Germany
        • +5 more
        Jun 27, 2022